3rd Surgical Clinic, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Institute of Pathological Anatomy, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Neoplasma. 2019 May 23;66(3):494-498. doi: 10.4149/neo_2018_180522N334.
In past decades, both prognosis and therapy of rectal cancer patients showed significant improvement, on the other hand, the incidence of rectal carcinoma continues to have a rising tendency. According to current UICC classification, patients in stage II rectal cancer or higher are indicated for neoadjuvant chemoradiotherapy (nCRT). Magnetic resonance imaging (MRI) is currently the most common diagnostic method used for preoperative staging of rectal cancer. Several studies already pointed out the inaccuracy of preoperative lymph node staging in patients with rectal cancer. The present study analyzed overall accuracy of MRI staging of rectal cancer and thus its accuracy in neoadjuvant therapy indication, by comparing preoperative MRI staging with definitive histopathologic results from resected tumors. This study evaluated cases of 92 patients with rectal tumor that underwent MRI examination followed by surgical resection. Tumors included in the analysis were ranging from T1 to T3b according to TNM staging, with free circumferential resection margin (CRM), distance form mesorectal fascia more than 5 mm, negative intersphincteric plane and also negative extramural venous invasion (EMVI), while the N stage was not decisive. In all cases both N-staging and T-staging were evaluated histologically and compared with preoperative MRI results. Significant difference in preoperative and postoperative N-staging was shown in 51 patients (61.45%). In majority of cases MRI lead to overstaging, which was observed in 44 cases (53.1 %), with complete negativity of lymph nodes proven by histological examination in 34 cases. On the other hand, understaging of lymph nodes was observed only in 7 cases (7.4 %). The T-staging did not show significant differences. Results from this study confirm that MRI plays an important role in T-staging of rectal tumors, however, there are admittedly issues in N-staging of tumors, which should lead to reevaluation of neoadjuvant therapy indication in patients with positive lymph nodes according to MRI examination. Based on the results of this study, we see the future of preoperative staging of rectal tumors in precise T-staging together with accurate assessment of CRM and distance of tumor from mesorectal fascia as well as evaluation of intersphinteric plane and EMVI.
在过去的几十年中,直肠癌患者的预后和治疗都有了显著的改善,另一方面,直肠癌的发病率仍呈上升趋势。根据目前的 UICC 分期,II 期及以上的直肠癌患者需要接受新辅助放化疗(nCRT)。磁共振成像(MRI)是目前用于直肠癌术前分期的最常用诊断方法。多项研究已经指出,直肠癌患者术前淋巴结分期存在不准确性。本研究通过比较术前 MRI 分期与切除肿瘤的明确组织病理学结果,分析直肠癌 MRI 分期的整体准确性及其在新辅助治疗适应证中的准确性。本研究评估了 92 例接受 MRI 检查后行手术切除的直肠肿瘤患者。分析的肿瘤根据 TNM 分期从 T1 到 T3b,包括环周切缘(CRM)无肿瘤侵犯、距直肠系膜筋膜>5mm、中直肠筋膜间隙无肿瘤侵犯和无外膜静脉侵犯(EMVI),但 N 分期不具决定性。所有病例均行术前和术后 N 分期的组织学评估,并与术前 MRI 结果进行比较。51 例(61.45%)患者的术前和术后 N 分期有显著差异。大多数情况下 MRI 导致过度分期,44 例(53.1%)证实淋巴结完全阴性,34 例组织学检查阴性。另一方面,仅观察到 7 例(7.4%)淋巴结分期不足。T 分期无显著差异。本研究结果证实,MRI 在直肠癌的 T 分期中起着重要作用,但肿瘤的 N 分期存在问题,这应导致根据 MRI 检查重新评估阳性淋巴结患者的新辅助治疗适应证。基于本研究的结果,我们认为,直肠癌术前分期的未来在于精确的 T 分期,同时准确评估 CRM 和肿瘤距直肠系膜筋膜的距离,以及评估中直肠筋膜间隙和 EMVI。